Retina/Vitreous News

ROME — Two injectable drugs with mitochondrial-stabilizing properties, risuteganib and elamipretide, show promise in reversing vision loss in dry age-related macular degeneration.

The FDA granted 510(k) clearance for the Eagle device, a Q-switched, 532 nm-wavelength, frequency-doubled Nd:YAG glaucoma laser for selective laser trabeculoplasty, according to a press release from Belkin Vision.

ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Albert Augustin, MD, speaks about the beneficial effects of metformin on age-related macular degeneration.

ROME —In this Healio Video Perspective from the FLORetina-ICOOR meeting, Matteo Forlini, MD, speaks about the surgeon’s choice between limited anterior vitrectomy or complete pars plana vitrectomy in case of secondary IOL implantation.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Jennifer I. Lim, MD, discusses the effect of faricimab on pigment epithelial detachments.

ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Serge Resnikoff, MD, PhD, chair of the International Myopia Institute, dispels some misconceptions regarding the cost of early management of myopia progression.

It is a well-known fact that individuals with diabetes have an increased likelihood of developing ocular complications.

ROME — The total estimated costs from inherited retinal diseases in the United States amounts to $31.8 billion. And yet, research barriers slow down the progress toward innovative treatment pathways, such as gene and cell therapies.

ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, Caroline Baumal, MD, presents data from the GALE study on pegcetacoplan for geographic atrophy in macular degeneration.

ROME — In this Healio Video Perspective from the FLORetina-ICOOR meeting, K. Bailey Freund, MD, speaks about laser-induced maculopathy.